News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Boehringer Ingelheim GmbH Unveils Laval Research Investment; New Jobs
May 28, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Boehringer Ingelheim, one of the world's 20 largest pharmaceutical research and development companies, yesterday unveiled a $36-million research centre in Laval that will specialize in infectious diseases such as Hepatitis C and HIV.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
Real estate
MORE ON THIS TOPIC
Layoff Tracker
Novartis cuts New Jersey workforce again, ousting 322 employees
July 8, 2026
·
67 min read
·
BioSpace Editorial Staff
Job Trends
Novartis slashes New Jersey workforce again, cutting 322 employees
July 7, 2026
·
1 min read
·
Angela Gabriel
Business
Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex
July 6, 2026
·
2 min read
·
Gabrielle Masson
Career Advice
The top 12 companies hiring in biopharma now
July 2, 2026
·
1 min read
·
Angela Gabriel